about
Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.In vitro effect of a thrombin inhibition peptide selected by phage display technology.Differential platelet deposition onto collagen in cone-and-plate and parallel plate flow chambers.Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates.4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix.Type 2B von Willebrand disease in seven individuals from three different families: phenotypic and genotypic characterization.Cyclic relapses of thrombotic thrombocytopenic purpura.Recirculated normal platelets adhere to surfaces coated with plasma from patients with immune thrombocytopenia.Coating conditions matter to collagen matrix formation regarding von Willebrand factor and platelet binding.Follow-up of thrombin generation after prostate cancer surgery: global test for increased hypercoagulability.Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis.High circulating osteoprotegerin levels are associated with non-zero blood groupsMannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic PatientsFactor XIII, clot structure, thrombosis.Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis.Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis.Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation.Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins.Present practice of thrombosis prophylaxis of radical prostatectomy in a European country: a Hungarian multicenter study.Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.Lipids associated with tissue transglutaminase.Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythaemia vera.Possible role for platelet insulin receptors in modulating platelet function in health and diabetes mellitus.Novel evaluation method for densitometric curves of von Willebrand factor multimers and a new parameter (M(MW)) to describe the degree of multimersation.Interaction between tissue transglutaminase and phospholipid vesicles.Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.Haptoglobin polymorphisms are associated with Crohn's disease, disease behavior, and extraintestinal manifestations in Hungarian patients.Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infectionsHaptoglobin Polymorphism: A Novel Genetic Risk Factor for Celiac Disease Development and Its Clinical ManifestationsShear-dependent morphology of von Willebrand factor bound to immobilized collagenBeta thromboglobulin and increased platelet activation after streptokinase treatment of acute myocardial infarctionAltered primary haemostasis in Conn's syndromeEffect of prostaglandin I2 on platelet adhesionNew pentamidine related substances which simultaneously inhibit platelet aggregation and accelerate plasmin generation and in vitro clot lysisAltered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitusEffect of recombinant human erythropoietin on plasma von Willebrand factor in chronic hemodialysis patientsTransglutaminase and receptor signaling: concepts and realitiesEffect of L-arginine on in vitro plasmin-generation and fibrinogenolysis
P50
Q30691871-A79D5278-0DDA-4D0E-8B82-1CB69A17DF62Q30884801-6B70F366-133C-4280-81C8-894C1CFA6520Q33243520-FC4D331B-AB32-4D84-B5DF-D6260FA31A34Q33262164-5DB7B709-9AC6-45DF-A73C-4A66D24D52B7Q33332419-5F904265-8E63-4923-A518-CA9061630F56Q33356115-677DD1B7-F1D8-4197-B9D6-29209E8606A7Q33375720-2A335E75-69F8-42C9-A07A-807641AB069FQ33491854-067CF3A3-5741-411E-8A70-B8C7E85D75ABQ33498968-449F8636-6763-4464-B65E-7DE2D7A50EFBQ34067909-28FF9D40-DD0A-4F8C-9451-1FE9BDBB8E36Q34510840-94DD33FD-F559-4142-A389-135831039661Q35716279-F7C362F0-4BF0-4D7E-ABDD-CB5B525EC376Q35962831-4BD9A110-3DB7-43F8-AE41-DD7957162791Q36069638-932EB7B9-E04D-4D2D-9179-CC0942FD314BQ36310396-A85AAD2D-0591-4D22-A31C-5DEEDA4CCEC8Q37971200-14E00275-7733-42E5-83A4-C910F43A0E68Q38930001-106B68AB-A0AC-4E15-8634-CFA27D2FEBC0Q39133826-F4EA2EB8-2DAF-4223-96DA-53248F5D11BCQ40417896-106BE901-92A5-4D4F-A490-75DC1E04EAFEQ40729681-C82F1013-E520-4DEE-AA96-BF015DA3EE15Q44784700-BC6146F1-E026-403E-B7DE-B0743A9BBA8DQ45183915-83265064-0DB9-40A7-AB37-00FCF40D5655Q46394328-6B162404-8C32-44EE-83F0-B528FD94295EQ47753223-ADE35CA1-12A8-4F29-B1DB-9A69F9A96F30Q47776716-420C5E3C-C7AA-4686-ADC8-CE47DAE06610Q50324459-EC383CD9-A3A2-49FF-B097-196E483A57CEQ53923414-D65583E7-D626-43B4-B568-8B0F0AA92529Q54443565-D5126F19-30F6-45CF-BC11-1BF8F42BD262Q55043586-B25A8F63-EF0A-4584-850A-0460CBA979F7Q57089314-704EADEE-853C-4308-AAEE-1F7299720523Q57089321-91E3995A-76F8-48C9-9FEC-EC3B02EFD100Q58481474-13A7E1EA-2D02-4886-B960-F52817952040Q67547248-57BC55F6-9BFE-4E5A-A88A-4C09D1A99429Q67591398-FAA5F19B-6DCE-4720-9275-1B62B0145FF0Q70152160-6ADC1BB8-CAF8-4A86-AED1-5FD4B3825D62Q71335940-9B8231A6-FD9A-4419-B820-056CF3C2F627Q71576030-8881EEB6-B036-456A-848F-B827B60FC601Q72204438-F899B8F7-B9BE-4D4D-9870-C3E7CC7B778FQ72598851-CC1E3892-2066-4C66-AE07-7C5F66FB6B0BQ73579068-52513505-8D12-4296-BE4B-E4746FA32BA4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jolan Harsfalvi
@ast
Jolan Harsfalvi
@en
Jolan Harsfalvi
@es
Jolan Harsfalvi
@nl
type
label
Jolan Harsfalvi
@ast
Jolan Harsfalvi
@en
Jolan Harsfalvi
@es
Jolan Harsfalvi
@nl
prefLabel
Jolan Harsfalvi
@ast
Jolan Harsfalvi
@en
Jolan Harsfalvi
@es
Jolan Harsfalvi
@nl
P106
P31
P496
0000-0001-9940-4846